The fluctuation of serum levels of aminotransferase in patients with nonalcoholic steatohepatitis [3]

Journal of Clinical Gastroenterology

Volumn 36, Issue 4, 2003, Pages 371-

  Ipekci, Süleyman H ^a   Basaranoglu, Metin ^a   Sonsuz, Abdullah ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; ENZYME BLOOD LEVEL; FATTY LIVER; HUMAN; LETTER; LIVER DISEASE; LIVER FUNCTION TEST; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; FATTY LIVER; FEMALE; HUMANS; LIVER FUNCTION TESTS; MALE; PROGNOSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0037376094     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200304000-00021     Document Type: Letter

References (5)

1. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002;34:255-62.
2. Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid of clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996; 23:1464-7.
3. Basaranoglu M, Acbay O, Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol 1999;31:384.
4. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-8.
5. Caldwell SH, Hespenheide EE, Redick JA, et al. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am J Gastroenterol 2001;96: 519-25.